家兔蓝斑复合核区对刺激下丘脑诱发室性期前收缩的影响

实验在72只乌拉坦,氯醛醣麻醉兔上进行,用三碘季铵酚制动,由人工呼吸机维持通气。用电刺激下丘脑近中线区的方法诱发室性期前收缩(HVE)。在蓝斑复合核区(Lc-Sc)微量注射吗啡(4μg溶于2μl中)可抑制 HVE;而微量注射乙酰胆碱(ACh)(50μg溶于2μl中)则可易化HVE。ACh 对 HVE 的这种易化效应可被中脑中央灰质(CG)或延髓中线区内微量注射心得安(20μg溶于2μl中)消除,但在 CG 或延髓中线区内微量注射酚妥拉明(10μg溶于1μl中)后仍存在。在 Ic-Sc 区微量注射纳洛酮(4μg溶于2μl中)或 ACh(50μg溶于2μl中),或用弱电流刺激一侧 Ic-Sc 区,均可阻断刺激腓深神经对 HVE 的抑制作用。电介损毁双侧 Lc-Sc 区后,刺激腓深神经对 HVE 的抑制效应有所增强。上述结果提示,吗啡和 ACh 对 Lc-Sc 区活动发生相互拮抗的影响。在 Lc-Sc 区微量注射 ACh,可能经 CG 及延髓中线区而发挥对 HVE 的易化作用。腓深神经对 HVE 的抑制效应并不依赖于 Lc-Sc 区的结构完整性。但 Lc-Sc 区的活动能抑制腓深神经的抑制效应。     

家兔缰核和导水管周围灰质内微量注射氯化钙拮抗电针和吗啡的镇痛作用

通过埋植套管向家兔双侧缰核或中脑导水管周围灰质(PAG)注射 CaCl_2每侧15—20nmol,对痛阈并无显著影响,但可使电针镇痛和吗啡(2rag/kg)镇痛效果明显降低。注入上述核团附近脑区则无效。双侧缰核注射的作用大于单侧。PAG 内注射 CaCl_2对抗电针镇痛的作用大于其对抗吗啡镇痛的作用。ca~(2 )对抗吗啡和电针镇痛的结果提示,吗啡或电针(释放内啡素)使神经元内 Ca~(2 )水平降低可能是吗啡或电针镇痛的共同机理。     

强啡肽A和CCK—8对大鼠脊髓突触小体摄取^45Ca的影响

为了探讨血管紧张素Ⅱ(AⅡ)和八肽胆囊收缩素(CCK-8)这两种肽的抗阿片作用机理,本实验中观察了三种阿片类物质(吗啡、强啡肽和 DPDPE)和两种抗阿片物质(AⅡ和 CCK-8)对大鼠脊髓突触小体摄取~(45) Ca 的影响。结果表明:(1)在脊髓腹柱突触小体上,10nmol/L—1μmol/L 的吗啡、强啡肽 A(Dyn A)和 DPDPE 对~(45)Ca 摄取均有较弱的抑制作用;(2)CCK-8在浓度高达lμmol/L 时对~(45)Ca 摄取有较弱的抑制作用;(3)AⅡ在浓度高达lμmol/L时也不影响腹柱突触小体摄取~(45)Ca;(4)在背柱的突触小体制备中,上述阿片物质中 Dyn A 对~(45)Ca 摄取有较强的抑制作用,并被 k 受体阻断剂 nor-BNI 所阻断。10和100nmol/L 的 CCK-8能翻转lμmol/L Dyn A 对~(45)Ca 摄取的抑制作用;(5)A Ⅱ不能翻转Dyn A 的抑制作用。以上结果提示,CCK-8阻断 Dyn A 抑制脊髓背柱突触小体摄取 Ca~(2+)的作用可能是其行为学中抗阿片作用的机理之一。AⅡ对脊髓 Ca~(2+)摄取和 Dyn A 抑制脊髓 Ca~(2+)摄取的作用皆无影响,与行为学中观察到的 AⅡ在脊髓内不能对抗阿片镇痛的现象一致,进一步说明 CCK-8和AⅡ拮抗阿片类物质对神经末梢 Ca~(2+)摄取的影响可能是其抗阿片作用的重要机理之一。     

下丘脑微量注射去甲肾上腺素增强电针镇痛作用的受体分析

向大鼠下丘脑腹内侧核区注射 NA 3μg/3μl 3小时后,电针镇痛的作用约增强6倍,持续长达24小时。此增强效应可被α-阻滞剂酚苄明(25μg/100μl)完全取消,但β-阻滞剂心得安(12.5μg/50μl)对它却无影响。这提示此增强作用通过α-受体而实现,与β-受体无关。又基于α_2-受体激动剂氯压啶的增强效应甚弱,α_2-阻滞剂育享平拮抗 NA 的增强作用弱于酚苄明,由此推论对电针效应的增强作用主要通过α_1-受体(即突触后受体)。纳络酮能拮抗大部分的增强效应,所以阿片受体也参与该增强作用。     

缰核痛相关神经元对伤害性刺激和吗啡的反应

目的:观察缰核痛相关神经元对经典镇痛药吗啡的反应,了解缰核的痛觉属性.方法:实验在浅麻醉下的成年大鼠进行.通过脑室插管微量注射,或经五管微电极电泳吗啡、纳络酮、八肽胆囊收缩素(CCK-8)等,并记录缰核内痛相关神经元的单位放电.结果:在内侧缰核、外侧缰核记录的痛相关神经元放电,又可分为痛兴奋性神经元和痛抑制性神经元.在缰核微电泳吗啡后,痛兴奋性神经元以抑制反应为主,痛抑制性神经元以兴奋反应为主.微电泳纳洛酮可以翻转吗啡对缰核的作用.在吗啡耐受大鼠腹腔注射吗啡10 mg/kg,LHb痛相关神经元表现为镇痛效应的数量远大于MHb痛相关神经元的,表明外侧缰核受吗啡的作用程度高于内侧缰核.对吗啡耐受大鼠脑室注入CCK拮抗剂后,再由腹腔注射吗啡,可减弱对吗啡的耐受程度.反之,在腹腔注射吗啡(10 mg/kg)10 min后,侧脑室注射CCK-8(15 ng/10μl),CCK-8可拮抗吗啡对LHb的镇痛作用,但对MHb的拮抗作用不明显.结论:缰核的痛兴奋性神经元和痛抑制性神经元对伤害性(痛)刺激敏感而不易发生适应.其中外侧缰核神经元对吗啡的敏感性高于内侧缰核神经元.     

钙离子与激素对小麦黄化幼苗离体核转录活性的影响

400μmol/LKT加于离体核反应液中后,核转录活性提高了50％左右;参入系统中加入5μmol/LCa~(2+),使核转录活性提高了90％,Ca~(2+)浓度大于500μmol/L时,产生负效应。La~(3+)及EGTA明显地消除Ca~(2+)的促进作用。钙调蛋白抑制剂酚噻嗪部分地减弱Ca~(2+)的促进作用;用酚噻嗪和KT同时处理离体核,则KT的促进作用大大削弱。     

吗啡和血管紧张素Ⅱ对大鼠脑突触小体Ca~(2 )摄取的拮抗效应

行为实验已多次证明,脑室注射血管紧张素Ⅱ(AⅡ)可以对抗吗啡的镇痛作用,但机制不明。吗啡阻止神经末梢钙摄取被认为是其镇痛的机理之一,因此本工作研究了AⅡ和吗啡对大鼠脑突触小体~(45)Ca摄取的作用及相互关系。结果表明,吗啡(10~(-8)—10~(-6)mol/L)对~(45)Ca摄取有明显的抑制作用,10~(-7)mol/L时抑制41％(P<0.001),该效应可被吗啡受体阻断剂纳洛酮(10~(-6)mol/L)完全翻转。与吗啡的作用相反,AⅡ(10~(-8)—110~(-6)mol/L)可促进突触小体对~(45)Ca的摄取,10~(-7)mol/L时增加75％(P<0.001),该效应可被AⅡ受体阻断剂Saralasin(10~(-6)mol/L)完全翻转。将不同剂量的AⅡ(10~(-8)—10~(-6)mol/L)和10~(-8)mol/L吗啡与突触小体共同孵育,则吗啡抑制~(45)Ca摄取的作用被完全翻转。以上结果表明,AⅡ促进脑突触小体Ca~(2 )摄取,对抗了吗啡抑制Ca~(2 )摄取的作用,可能是AⅡ抗吗啡镇痛的机制之一。     

青霉素和苯巴比妥钠对小鼠全脑切片积聚~3H-GABA的影响

本文应用同位素示踪、脑片离体培育和侧脑室注射的方法,在体外和体内研究了惊厥剂青霉素和抗惊厥剂苯巴比妥钠对小白鼠全脑切片积聚~3H-GABA的影响。结果表明:(1)在含6.70—13.40×10~(-4)mol/L的苄青霉素钾(PG)100μl或19.60—39.20×10~(-4)mol/L的苯巴比妥钠(PhB)50μl的培育液(2ml)中,小鼠全脑切片对~3H-GABA的积聚作用明显降低(P<0.05)。6.70×10~(-4)mol/L的PG100μl和39.20×10~(-4)mol/L的PhB50μl同时注入培育液(2ml)时,脑片对~3H-GABA的积聚比PG单独试验时稍有升高。(2 )小鼠侧脑室注射20μl的 3.35×10~(-2)mol/L的PG可引起强烈的惊厥,脑片上的~3H-GABA积聚减少(P>0.05);脑室内注射10μl的3.88×10~(-2)mol/L的PhB能抗惊厥,也使~3H-GABA在脑片上的积聚减少(P>0.05);脑室内同时注射PG和PhB,使~3H-GABA在脑片上的积聚恢复正常。以上结果提示:青霉素可通过竞争突触后膜和神经末梢上的GABA受体,阻断GA-BA的突触后抑制效应及抑制GABA释放,显示惊厥作用;苯巴比妥钠也可和突触后膜上的GABA受体结合,产生GABA样作用或激活GABA受体,起抗惊厥作用。     

家兔延髓腹侧区内注射吗啡对刺激下丘脑诱发室性期前收缩的抑制作用

家免63只,用乌拉坦(700mg/kg)和氯醛醣(35mg/kg)静脉麻醉,三碘季铵酚制动,在人工呼吸下进行实验。用电刺激下丘脑近中线区的方法诱发定性期前收缩(HVE)。双侧延髓腹侧区内微量注射吗啡(5μg 溶于0.5—1μl 中)可抑制 HVE。在双侧延髓腹侧区微量注射纳洛酬(2μg 溶于0.5—1μl 中)能阻断电刺激中缝核尾端或中缝核尾端内微量注射 L-谷氨酸钠(50mmol/L,0.5—1μl)对 HVE 的抑制效应,也能减少或消除刺激腓深神经对 HVE 的抑制作用。上述结果提示,延髓腹侧部阿片受体的激活可抑制 HVE;另外,腓深神经传入冲动也可能通过中缝核尾端激活延髓腹侧区的阿片受体而抑制 HVE。     

外源Ca^2＋对烟草花粉管生长和生殖核分裂的调节

用细胞学和统计学方法研究了外源Ca~(2 )对烟草(Nicotiana tabacum L.)离体花粉管生长和生殖核分裂的影响。正常培养条件下,花粉管群体内的生殖核分裂率大致呈对数增长,10～18h为其分裂高峰期。所用Ca~(2 )浓度中以10~(-3)mol/L最适于花粉管生长,与之相比,其它浓度随时间延长愈益明显地表现出抑制效应。生殖核分裂则以10~(-2)与10~(-3)mol/L较为适宜,且10~(-2)mol/L可相对提前分裂高峰。在含10~(-3)mol/L Ca~(2 )培养基中培养10h后用不同方法处理,发现高钙抑制花粉管生长,尤以10~(-1)mol/L Ca~(2 )抑制最强烈,导致花粉管顶端壁加厚及生殖核的无丝分裂。而10~(-2)mol/L Ca~(2 )在处理早期(10～12h)促进生殖核分裂。EGTA处理则同时抑制花粉管生长和生殖核分裂。     

家兔延髓腹外侧区内注射荷包牡丹碱对安定降低心脏功能的影响

家兔48只,用乌拉坦(1g/kg)静脉麻醉,三碘季铵酚制动,在人工呼吸下进行实验。静脉注射安定(0.5mg/kg)以及侧脑室注射氟安定(2mg溶于50μl人工脑脊液中)或γ-氨基丁酸(GABA)(300μg溶于50μl人工脑脊液中)都可降低心室内压峰值(PLVP),减少心力环面积(ACFL)和心室内压最大上升速率(dp/dt_(max))。安定和氟安定对PLVP、ACFL和dp/dt_(max)的抑制作用可被预先在侧脑室注射GABA受体拮抗剂印防己毒素(15μg溶于50μl人工脑脊液中)或双侧延髓腹外侧头端区(γVLM)微量注射GABA受体拮抗剂荷包牡丹碱(3μg溶于0.5μl生理盐水)所阻断。而在延髓网状巨细胞核中间部、网状小细胞核、孤束核或面神经核内注射同样剂量的荷包牡丹碱则不能阻断。 这些结果提示:延髓腹侧部GABA受体的激活可抑制心脏功能,安定对心脏功能的抑制作用可能通过激活延髓腹侧区GABA受体而实现。     

家兔中脑导水管周围灰质中注射八肽胆囊收缩素（CCK—8）拮抗吗啡镇痛和...

We have reported that intracerebroventricular (i. c. v.) injection of 1-4 ng of CCK-8 to the rat produced a remarkable antagonistic effect on morphine analgesia. In order to study the species specificity and the site of action, CCK-8 was microinjected into the PAG of the rabbit, and its influence on morphine analgesia and electroacupuncture analgesia was observed. The latency of the escape response (ERL) to radiant heat focused on the snout was measured as an index of the pain threshold. Microinjections were made via cannulae chronically implanted into the PAG. The drug solutions were delivered in a volume of 1 microliter, at a speed of 0.125 microliter/min. The ERL was measured for a period of 60 or 70 minutes at 10 min intervals. 1. CCK-8 administered unilaterally to the PAG of the rabbit at a dose of 3 ng antagonized the analgesia induced by morphine (4 mg/kg, i. v.) by 73% (P less than 0.001), and reduced the analgesic effect of electroacupuncture by 67% (P less than 0.001). These effects were dose-dependent within the range from 1.5 ng to 6.0 ng. The effect of CCK-8 was reversed by CCK receptor blocker proglumide (4 microliters, intra-PAG injection). Unsulfated CCK-8 (CCK-us) had no effect in this regard. These results indicate that in the PAG of the rabbit, exogenously administered CCK-8 was capable of antagonizing opioid analgesia by the activation of CCK receptors. 2. Two groups of rabbits were given with morphine (2 mg/kg, i. v.) and simultaneous injection of CCK-8 antiserum (CCK-AS, 1 microliter) or normal rabbit serum (NRS) into the PAG.(ABSTRACT TRUNCATED AT 250 WORDS)     

Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens

Dopaminergic nerve endings in the corpus striatum possess nicotinic (nAChRs) and muscarinic cholinergic receptors (mAChRs) mediating release of dopamine (DA). Whether nAChRs and mAChRs co-exist and interact on the same nerve endings is unknown. We here investigate on these possibilities using rat nucleus accumbens synaptosomes pre-labeled with [³H]DA and exposed in superfusion to cholinergic receptor ligands. The mixed nAChR–mAChR agonists acetylcholine (ACh) and carbachol provoked [³H]DA release partially sensitive to the mAChR antagonist atropine but totally blocked by the nAChR antagonist mecamylamine. Addition of the mAChR agonist oxotremorine at the minimally effective concentration of 30 μmol/L, together with 3, 10, or 100 μmol/L (−)nicotine provoked synergistic effect on [³H]DA overflow. The [³H]DA overflow elicited by 100 μmol/L (−)nicotine plus 30 μmol/L oxotremorine was reduced by atropine down to the release produced by (−)nicotine alone and it was abolished by mecamylamine. The ryanodine receptor blockers dantrolene or 8-bromo-cADP-ribose, but not the inositol 1,4,5-trisphosphate receptor blocker xestospongin C inhibited the (−)nicotine/oxotremorine evoked [³H]DA overflow similarly to atropine. This overflow was partly sensitive to 100 nmol/L methyllycaconitine which did not prevent the synergistic effect of (−)nicotine/oxotremorine. Similarly to (−)nicotine, the selective α4β2 nAChR agonist RJR2403 exhibited synergism when added together with oxotremorine. To conclude, in rat nucleus accumbens, α4β2 nAChRs exert a permissive role on the releasing function of reportedly M₅ mAChRs co-existing on the same dopaminergic nerve endings.     

乙酰胆碱对培养T细胞功能的作用

本文研究不同浓度（１０＾－１０－１０＾－４ｍｏｌ／Ｌ）乙酰胆碱（ＡＣｈ）对离体培养的大鼠脾脏Ｔ淋巴细胞增殖的影响,并探讨其作用机制。实验结果表明：１０＾－９－１０＾－４ｍｏｌ／Ｌ可显著增强Ｔ细胞由刀豆素Ａ（Ｃ－Ａ）诱导的增殖反应,以１０＾－７－１０＾－６ｍｏｌ／Ｌ时最强。淋巴细胞先用ＡＣｈ刺激１ｈ或者刺激１ｈ后洗弃ＡＣｈ,再用ＣｏｎＡ诱导６ｈ的Ｔ细胞的增殖。１０＾－７－１０－６ｍｏｌ／Ｌ阿托品可阻     

安定降低家兔血压和减少刺激下丘脑诱发室性期前收缩的机制分析

家兔62只,用乌拉坦(700mg/kg)和氯醛醣(35mg/kg)静脉麻醉,三碘季铵酚制动,在人工呼吸下进行实验。用电刺激下丘脑近中线区的方法诱发室性期前收缩(HVE)。静脉注射安定(0.5mg/kg)可降低基础血压(BP),减弱刺激下丘脑引起升压反应(指收缩压峰值SBP_(max))和减少HVE。在双侧延髓腹外侧头端区(rVLM)微量注射氟安定(200μg溶于0.5μl中),γ-氨基丁酸(GABA)(6μg溶于0.5μl中)均能降低BP、SBP_(max)和减少HVE,若微量注射印防己毒素(7.5μg溶于0.5μl中)则可使BP上升并增多HVE。而于双侧延髓腹外侧尾端区(cVLM)微量注射同样剂量氟安定、GABA则无上述反应。安定降低BP、SBP_(max)和减少HVE的作用可被双侧rVLM区微量注射GABA受体拮抗剂荷包牡丹碱(3μg溶于0.5μl中)或印防己毒素所消除,但在双侧rVLM区微量注射甘氨酸受体拮抗剂士的宁(1μg溶于0.5μl中)、阿片受体拮抗剂纳洛酮(0.5μg溶于0.5μl中)、胆碱能阻断药阿托品(0.25μg溶于0.5μl中)、东莨菪碱(1.5μg溶于0.5μl中)后仍然存在。 上述结果提示,在双侧rVLM应用GABA受体拮抗剂可消除安定降低BP、SBP_(max)和减少HVE的作用,安定降低BP、SBP_(max)和减少HVE的作用可能通过GABA这一中间环节,而胆碱能受体、阿片受体、甘氨酸受体可能不起重要作用。     

家兔隔核中去甲肾上腺素对皮肤与内脏痛阈的影响

本工作以电刺激内脏大神经或耳尖部皮肤测定清醒家兔内脏痛阈或皮肤痛阈,以探讨隔核去甲肾上腺素在内脏镇痛和皮肤镇痛中的作用以及与中脑导水管周围灰质(PAG)中内阿片肽系统的关系。实验观察到,双侧隔核内微量注射α受体激动剂可乐宁(10μg/2μl)或α受体阻断剂酚妥拉明(10μg/2μl)对内脏痛阈无明显影响。注入β受体激动剂异丙肾上腺素(1μg/2μl)使内脏痛阐明显升高;而注入β受体阻断剂心得安(1Cμg/2μl)则内脏痛阈明显降低。隔核内注入酚妥拉明(10μg/2μl)或心得安(10μg/2μl)均可使皮肤痛阈明显提高。提示,隔核内NA通过β受体调制内脏痛;通过α受体和β受体调制皮肤痛。隔核内注入异丙肾上腺素(1μg/2μl)明显地镇内脏痛,此作用可被PAG内注射纳洛酮(1μg/2μl)或注射抗亮啡肽抗血清(1:20,000)所减弱;但可使PAG内亮啡肽样物质释放量增加。这提示,隔核内NA的镇内脏痛作用与PAG的内阿片肽系统有关;其中亮非肽在这一过程中具有重要作用。     

乙酰胆碱对大鼠体外抗体生成的影响

目的：观察不同浓度乙酰胆碱（ＡＣｈ,１０－１０～１０－５ｍｏｌ／Ｌ）对大鼠体外抗体生成的影响,并初步探讨其作用机制,从细胞水平了解乙酰胆碱与免疫功能之间的关系。方法：用体外抗体生成的检测方法,用绵羊红细胞（ＳＲＢＣ）刺激大鼠肠系膜淋巴结Ｂ细胞转化成抗体形成细胞（ＡＦＣ）,然后检测其抗体生成量。结果：①１０－１０～１０－７ｍｏｌ／ＬＡＣｈ能显著抑制体外抗体生成,其中１０－８和１０－７ｍｏｌ／ＬＡＣｈ的作用较强,而１０－６和１０－５ｍｏｌ／ＬＡＣｈ无明显的抑制作用;②Ｍ型胆碱能受体激动剂毛果芸香碱（１０－８和１０－７ｍｏｌ／Ｌ）能明显减弱体外抗体生成,而Ｎ型受体激动剂烟碱（１０－８和１０－７ｍｏｌ／Ｌ）没有显著的减弱作用,Ｍ型受体拮抗剂阿托品（１０－７和１０－６ｍｏｌ／Ｌ）可完全阻断ＡＣｈ抑制体外抗体生成的作用;③ＡＣｈ分别在Ｂ细胞用ＳＲＢＣ刺激后３～４８ｈ中的６个不同时间与淋巴细胞作用,其抗体生成仍然是减少的。结论：ＡＣｈ可非浓度依赖性地抑制大鼠的体外抗体生成;此作用可能由Ｂ细胞上的Ｍ型胆碱能受体介导;且ＡＣｈ可能主要影响Ｂ细胞转化的后期过程。     

下丘脑室旁核加压素能神经元参与电针刺激对实验性...

It has been demonstrated in animal model of somatic pain that hypothalamic paraventricular nucleus (PVN) participates in acupuncture analgesia, probably by mediation of vasopressin release. The role of PVN in acupuncture analgesia for experimental visceral pain in rats was further investigated in the present study. Experimental results demonstrated that electroacupuncture could inhibit the writhing response, produced by intraperitoneal injection of antimonium potassium tartrate and this inhibitory effect could be enhanced by electrical stimulation of PVN, but decreased by electrolytical lesion of PVN, intracerebroventricular injection of vasopressin antiserum (14 microliters) or the vasopressin antagonist, d(CH2)5Tyr(Me)-AVP (500 ng/5 microliters). Intraperitoneal administration of the latter drug (10 micrograms/kg), however, was ineffective. The above experimental results suggest that vasopressinergic neurons in PVN also participate in the inhibition of visceral pain by electroacupuncture.     

Involvement of Dihydropyridine-Sensitive Ca2+ Channels in Adenosine-Evoked Inhibition of Acetylcholine Release from Guinea Pig Ileal Preparation

The effects of adenosine and nifedipine on endogenous acetylcholine (ACh) release evoked by electrical stimulation from guinea pig ileal longitudinal muscle preparations exposed to physostigmine were evaluated using an HPLC with electrochemical detection (ECD) system. Resting ACh release, which was sensitive to tetrodotoxin (0.3 microM), was enhanced by Bay K 8644 (0.5 microM; a Ca2+ antagonist) or 4-aminopyridine (30 microM; a K+ channel blocker) but not by theophylline (100 microM; a P1 purinoceptor antagonist) or atropine (0.3 microM). The enhancement of the resting ACh release by Bay K 8644 was virtually unaffected by atropine. Electrically evoked ACh release was enhanced by around two- to fourfold in the presence of theophylline, atropine, Bay K 8644, 4-aminopyridine, or atropine. On the other hand, the evoked ACh release was reduced by adenosine (10-30 microM), nifedipine (0.1-0.3 microM; a dihydropyridine Ca2+ channel antagonist), or bethanechol (1-3 microM) in a concentration-related fashion. The reduction induced by adenosine or nifedipine was almost abolished by either theophylline or Bay K 8644, whereas that induced by bethanechol was virtually unaffected by these drugs. The inhibition by adenosine of ACh release was not influenced in the presence of 4-aminopyridine or atropine. However, this inhibition by adenosine was considerably enhanced by halving the Ca2+ concentration in the Krebs solution and was diminished by doubling the Ca2+ concentration. These findings suggest that adenosine produces a cholinergic neuromodulation presumably via modifying dihydropyridine-sensitive Ca2+ channel activities in the cholinergic neurons, and thus L-type Ca2+ channels may exist on the nerve terminals.(ABSTRACT TRUNCATED AT 250 WORDS)     

乙酰胆碱对蟾蜍背根神经节神经元膜电位的影响及离子机制

在离体灌流的蟾蜍背根神经节(DRG)标本上,用微电极进行胞内记录。在73个神经元中,依神经纤维的传导速度将神经元分为 A 型及 C 型,其中 A 型细胞67个,C 型6个,静息膜电位为-67.5±1.3mV((?)±SE)。当加4×10~(-4)—6×10~(-4)mol/L 乙酰胆碱(ACh),可观察到如下四种膜电位变化:1.超极化:幅值9.1±3.0mV((?)±SE,n=23);(2)去极化:幅值12.9±2.2mV((?)+SE,n=20);(3)双相反应(n=24):先超极化,后去极化,超极化幅值8.0±2.4mV((?)+SE),去极化幅值10.9±3.1mV((?)±SE);(4)无反应(n=6)。用阿托品(1.3×10~(-5)mol/L,n=23),或同时应用筒箭毒与六甲双铵(浓度均为1.4×10~(-5)mol/L,n=8)灌流,能分别阻断 ACh 引起的膜的超极化或去极化。ACh 引起超极化反应时膜电导平均增加13.8%,翻转电位值大约-96mV。四乙铵(TEA,20mmol/L)能使 ACh 的去极化幅值增加48.2±3.2%((?)±SE,n=6),超极化幅值减小79.4±4.3%((?)±SE,n=8)。MnCl_2(4mmol/L)使 ACh 的去极化及超极化幅值分别减小54.2±7.2%((?)±SE,n=5)及69.2±6.4%((?)±SE,n=14)。以上结果提示:ACh 引起的 DRG 神经细胞膜去极化反应由 N 型乙酰胆碱受体介导,而超极化反应由 Μ 型乙酰胆碱受体介导,前者可能包含了多种离子电导的改变,后者则可能与钾电导增加有关。